nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Abnormal pigmentation—Temozolomide—melanoma	0.0878	0.141	CcSEcCtD
Propericiazine—Pigmentation disorder—Temozolomide—melanoma	0.0248	0.0397	CcSEcCtD
Propericiazine—Traumatic liver injury—Temozolomide—melanoma	0.0222	0.0356	CcSEcCtD
Propericiazine—Altered state of consciousness—Temozolomide—melanoma	0.0179	0.0287	CcSEcCtD
Propericiazine—Deep vein thrombosis—Temozolomide—melanoma	0.0136	0.0218	CcSEcCtD
Propericiazine—Photosensitivity—Vemurafenib—melanoma	0.0134	0.0214	CcSEcCtD
Propericiazine—Menorrhagia—Temozolomide—melanoma	0.0112	0.0179	CcSEcCtD
Propericiazine—Aggression—Bleomycin—melanoma	0.0112	0.0179	CcSEcCtD
Propericiazine—Eosinophilia—Vemurafenib—melanoma	0.0101	0.0161	CcSEcCtD
Propericiazine—Menstruation irregular—Docetaxel—melanoma	0.00995	0.0159	CcSEcCtD
Propericiazine—Liver injury—Temozolomide—melanoma	0.00984	0.0157	CcSEcCtD
Propericiazine—Amenorrhoea—Temozolomide—melanoma	0.00943	0.0151	CcSEcCtD
Propericiazine—Photosensitivity reaction—Vemurafenib—melanoma	0.00928	0.0148	CcSEcCtD
Propericiazine—Deep vein thrombosis—Docetaxel—melanoma	0.00905	0.0145	CcSEcCtD
Propericiazine—Pulmonary embolism—Carmustine—melanoma	0.00857	0.0137	CcSEcCtD
Propericiazine—Pulmonary embolism—Temozolomide—melanoma	0.00828	0.0132	CcSEcCtD
Propericiazine—Gynaecomastia—Carmustine—melanoma	0.00767	0.0123	CcSEcCtD
Propericiazine—Cardiac disorder—Vemurafenib—melanoma	0.00755	0.0121	CcSEcCtD
Propericiazine—Nasal congestion—Temozolomide—melanoma	0.0066	0.0106	CcSEcCtD
Propericiazine—Amenorrhoea—Docetaxel—melanoma	0.00627	0.01	CcSEcCtD
Propericiazine—Infection—Vemurafenib—melanoma	0.00574	0.00919	CcSEcCtD
Propericiazine—Hypokalaemia—Carmustine—melanoma	0.00566	0.00906	CcSEcCtD
Propericiazine—Pneumonia—Bleomycin—melanoma	0.00552	0.00884	CcSEcCtD
Propericiazine—Pulmonary embolism—Docetaxel—melanoma	0.00551	0.00881	CcSEcCtD
Propericiazine—Hypokalaemia—Temozolomide—melanoma	0.00547	0.00875	CcSEcCtD
Propericiazine—Hypotension—Vemurafenib—melanoma	0.0054	0.00864	CcSEcCtD
Propericiazine—Pneumonia—Dactinomycin—melanoma	0.00515	0.00824	CcSEcCtD
Propericiazine—Sweating increased—Temozolomide—melanoma	0.00506	0.0081	CcSEcCtD
Propericiazine—Constipation—Vemurafenib—melanoma	0.00494	0.00791	CcSEcCtD
Propericiazine—Hyperglycaemia—Carmustine—melanoma	0.00485	0.00776	CcSEcCtD
Propericiazine—Pneumonia—Carmustine—melanoma	0.00482	0.00771	CcSEcCtD
Propericiazine—Erectile dysfunction—Temozolomide—melanoma	0.00479	0.00765	CcSEcCtD
Propericiazine—Agranulocytosis—Dactinomycin—melanoma	0.00478	0.00765	CcSEcCtD
Propericiazine—Photosensitivity reaction—Temozolomide—melanoma	0.00474	0.00759	CcSEcCtD
Propericiazine—Weight increased—Temozolomide—melanoma	0.00473	0.00756	CcSEcCtD
Propericiazine—Hyperglycaemia—Temozolomide—melanoma	0.00469	0.0075	CcSEcCtD
Propericiazine—Pneumonia—Temozolomide—melanoma	0.00466	0.00745	CcSEcCtD
Propericiazine—Body temperature increased—Vemurafenib—melanoma	0.00457	0.00731	CcSEcCtD
Propericiazine—Hypersensitivity—Vemurafenib—melanoma	0.00426	0.00681	CcSEcCtD
Propericiazine—Diarrhoea—Vemurafenib—melanoma	0.00396	0.00633	CcSEcCtD
Propericiazine—Cardiac disorder—Temozolomide—melanoma	0.00386	0.00617	CcSEcCtD
Propericiazine—Arrhythmia—Carmustine—melanoma	0.00384	0.00615	CcSEcCtD
Propericiazine—Vomiting—Vemurafenib—melanoma	0.00368	0.00588	CcSEcCtD
Propericiazine—Rash—Vemurafenib—melanoma	0.00365	0.00583	CcSEcCtD
Propericiazine—Dermatitis—Vemurafenib—melanoma	0.00364	0.00582	CcSEcCtD
Propericiazine—Confusional state—Bleomycin—melanoma	0.00353	0.00565	CcSEcCtD
Propericiazine—Vision blurred—Carmustine—melanoma	0.00353	0.00565	CcSEcCtD
Propericiazine—Tremor—Carmustine—melanoma	0.00351	0.00561	CcSEcCtD
Propericiazine—Oedema—Bleomycin—melanoma	0.0035	0.0056	CcSEcCtD
Propericiazine—Infection—Bleomycin—melanoma	0.00348	0.00557	CcSEcCtD
Propericiazine—Agitation—Carmustine—melanoma	0.00344	0.00551	CcSEcCtD
Propericiazine—Nausea—Vemurafenib—melanoma	0.00343	0.00549	CcSEcCtD
Propericiazine—Vision blurred—Temozolomide—melanoma	0.00341	0.00546	CcSEcCtD
Propericiazine—Tremor—Temozolomide—melanoma	0.00339	0.00543	CcSEcCtD
Propericiazine—Agitation—Temozolomide—melanoma	0.00333	0.00532	CcSEcCtD
Propericiazine—Angioedema—Temozolomide—melanoma	0.00331	0.00529	CcSEcCtD
Propericiazine—Hypotension—Bleomycin—melanoma	0.00327	0.00523	CcSEcCtD
Propericiazine—Oedema—Dactinomycin—melanoma	0.00327	0.00522	CcSEcCtD
Propericiazine—Infection—Dactinomycin—melanoma	0.00325	0.00519	CcSEcCtD
Propericiazine—Weight increased—Docetaxel—melanoma	0.00314	0.00503	CcSEcCtD
Propericiazine—Dyspnoea—Bleomycin—melanoma	0.00312	0.00499	CcSEcCtD
Propericiazine—Pneumonia—Docetaxel—melanoma	0.0031	0.00496	CcSEcCtD
Propericiazine—Confusional state—Carmustine—melanoma	0.00308	0.00493	CcSEcCtD
Propericiazine—Oedema—Carmustine—melanoma	0.00306	0.00489	CcSEcCtD
Propericiazine—Infection—Carmustine—melanoma	0.00304	0.00486	CcSEcCtD
Propericiazine—Dry mouth—Temozolomide—melanoma	0.00301	0.00482	CcSEcCtD
Propericiazine—Jaundice—Docetaxel—melanoma	0.003	0.0048	CcSEcCtD
Propericiazine—Tachycardia—Carmustine—melanoma	0.00298	0.00477	CcSEcCtD
Propericiazine—Confusional state—Temozolomide—melanoma	0.00298	0.00477	CcSEcCtD
Propericiazine—Oedema—Temozolomide—melanoma	0.00295	0.00473	CcSEcCtD
Propericiazine—Infection—Temozolomide—melanoma	0.00294	0.00469	CcSEcCtD
Propericiazine—Agranulocytosis—Docetaxel—melanoma	0.00288	0.0046	CcSEcCtD
Propericiazine—Hypotension—Carmustine—melanoma	0.00286	0.00457	CcSEcCtD
Propericiazine—Hyperhidrosis—Temozolomide—melanoma	0.00286	0.00457	CcSEcCtD
Propericiazine—Body temperature increased—Bleomycin—melanoma	0.00277	0.00443	CcSEcCtD
Propericiazine—Insomnia—Carmustine—melanoma	0.00277	0.00442	CcSEcCtD
Propericiazine—Dyspnoea—Carmustine—melanoma	0.00273	0.00436	CcSEcCtD
Propericiazine—Somnolence—Carmustine—melanoma	0.00272	0.00435	CcSEcCtD
Propericiazine—Insomnia—Temozolomide—melanoma	0.00267	0.00427	CcSEcCtD
Propericiazine—Dyspnoea—Temozolomide—melanoma	0.00263	0.00421	CcSEcCtD
Propericiazine—Somnolence—Temozolomide—melanoma	0.00263	0.0042	CcSEcCtD
Propericiazine—Constipation—Carmustine—melanoma	0.00261	0.00418	CcSEcCtD
Propericiazine—Body temperature increased—Dactinomycin—melanoma	0.00258	0.00413	CcSEcCtD
Propericiazine—Hypersensitivity—Bleomycin—melanoma	0.00258	0.00413	CcSEcCtD
Propericiazine—Cardiac disorder—Docetaxel—melanoma	0.00257	0.00411	CcSEcCtD
Propericiazine—Constipation—Temozolomide—melanoma	0.00253	0.00404	CcSEcCtD
Propericiazine—Arrhythmia—Docetaxel—melanoma	0.00247	0.00395	CcSEcCtD
Propericiazine—Body temperature increased—Carmustine—melanoma	0.00242	0.00387	CcSEcCtD
Propericiazine—Hypersensitivity—Dactinomycin—melanoma	0.00241	0.00385	CcSEcCtD
Propericiazine—Body temperature increased—Temozolomide—melanoma	0.00234	0.00374	CcSEcCtD
Propericiazine—Hypersensitivity—Carmustine—melanoma	0.00225	0.0036	CcSEcCtD
Propericiazine—Diarrhoea—Dactinomycin—melanoma	0.00224	0.00357	CcSEcCtD
Propericiazine—Vomiting—Bleomycin—melanoma	0.00223	0.00356	CcSEcCtD
Propericiazine—Rash—Bleomycin—melanoma	0.00221	0.00353	CcSEcCtD
Propericiazine—Dermatitis—Bleomycin—melanoma	0.00221	0.00353	CcSEcCtD
Propericiazine—Hypersensitivity—Temozolomide—melanoma	0.00218	0.00348	CcSEcCtD
Propericiazine—Diarrhoea—Carmustine—melanoma	0.00209	0.00335	CcSEcCtD
Propericiazine—Nausea—Bleomycin—melanoma	0.00208	0.00333	CcSEcCtD
Propericiazine—Vomiting—Dactinomycin—melanoma	0.00208	0.00332	CcSEcCtD
Propericiazine—Rash—Dactinomycin—melanoma	0.00206	0.00329	CcSEcCtD
Propericiazine—Diarrhoea—Temozolomide—melanoma	0.00202	0.00323	CcSEcCtD
Propericiazine—Dry mouth—Docetaxel—melanoma	0.002	0.00321	CcSEcCtD
Propericiazine—Confusional state—Docetaxel—melanoma	0.00198	0.00317	CcSEcCtD
Propericiazine—Oedema—Docetaxel—melanoma	0.00196	0.00314	CcSEcCtD
Propericiazine—Infection—Docetaxel—melanoma	0.00195	0.00312	CcSEcCtD
Propericiazine—Vomiting—Carmustine—melanoma	0.00194	0.00311	CcSEcCtD
Propericiazine—Nausea—Dactinomycin—melanoma	0.00194	0.0031	CcSEcCtD
Propericiazine—Rash—Carmustine—melanoma	0.00193	0.00308	CcSEcCtD
Propericiazine—Dermatitis—Carmustine—melanoma	0.00193	0.00308	CcSEcCtD
Propericiazine—Tachycardia—Docetaxel—melanoma	0.00192	0.00307	CcSEcCtD
Propericiazine—Vomiting—Temozolomide—melanoma	0.00188	0.003	CcSEcCtD
Propericiazine—Rash—Temozolomide—melanoma	0.00186	0.00298	CcSEcCtD
Propericiazine—Dermatitis—Temozolomide—melanoma	0.00186	0.00298	CcSEcCtD
Propericiazine—Hypotension—Docetaxel—melanoma	0.00184	0.00294	CcSEcCtD
Propericiazine—Nausea—Carmustine—melanoma	0.00182	0.0029	CcSEcCtD
Propericiazine—Insomnia—Docetaxel—melanoma	0.00178	0.00284	CcSEcCtD
Propericiazine—Nausea—Temozolomide—melanoma	0.00176	0.00281	CcSEcCtD
Propericiazine—Dyspnoea—Docetaxel—melanoma	0.00175	0.0028	CcSEcCtD
Propericiazine—Somnolence—Docetaxel—melanoma	0.00175	0.00279	CcSEcCtD
Propericiazine—Constipation—Docetaxel—melanoma	0.00168	0.00269	CcSEcCtD
Propericiazine—Body temperature increased—Docetaxel—melanoma	0.00155	0.00248	CcSEcCtD
Propericiazine—Hypersensitivity—Docetaxel—melanoma	0.00145	0.00232	CcSEcCtD
Propericiazine—Diarrhoea—Docetaxel—melanoma	0.00134	0.00215	CcSEcCtD
Propericiazine—Vomiting—Docetaxel—melanoma	0.00125	0.002	CcSEcCtD
Propericiazine—Rash—Docetaxel—melanoma	0.00124	0.00198	CcSEcCtD
Propericiazine—Dermatitis—Docetaxel—melanoma	0.00124	0.00198	CcSEcCtD
Propericiazine—Nausea—Docetaxel—melanoma	0.00117	0.00187	CcSEcCtD
Propericiazine—Domperidone—ABCB1—melanoma	0.000654	0.112	CrCbGaD
Propericiazine—Triflupromazine—ABCB1—melanoma	0.000529	0.0905	CrCbGaD
Propericiazine—Acepromazine—ALB—melanoma	0.000513	0.0877	CrCbGaD
Propericiazine—Thioproperazine—ALB—melanoma	0.000502	0.0857	CrCbGaD
Propericiazine—Pipotiazine—ALB—melanoma	0.000494	0.0844	CrCbGaD
Propericiazine—Thiothixene—ALB—melanoma	0.000494	0.0844	CrCbGaD
Propericiazine—Fluphenazine—ABCB1—melanoma	0.000407	0.0696	CrCbGaD
Propericiazine—Clomipramine—ALB—melanoma	0.00039	0.0667	CrCbGaD
Propericiazine—Clomipramine—ABCB1—melanoma	0.000372	0.0636	CrCbGaD
Propericiazine—Promethazine—ABCB1—melanoma	0.00033	0.0564	CrCbGaD
Propericiazine—Trifluoperazine—ABCB1—melanoma	0.000325	0.0556	CrCbGaD
Propericiazine—Quetiapine—ABCB1—melanoma	0.000316	0.0539	CrCbGaD
Propericiazine—Chlorpromazine—ALB—melanoma	0.000268	0.0457	CrCbGaD
Propericiazine—Chlorpromazine—ABCB1—melanoma	0.000255	0.0436	CrCbGaD
Propericiazine—ADRA1B—Signaling Pathways—AKT3—melanoma	0.000129	0.000349	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PTK2B—melanoma	0.000127	0.000345	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—IL2—melanoma	0.000127	0.000345	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—E2F1—melanoma	0.000126	0.000342	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PIK3CB—melanoma	0.000126	0.000341	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PDGFRA—melanoma	0.000125	0.000339	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GAB2—melanoma	0.000124	0.000336	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GNA11—melanoma	0.000124	0.000336	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ITGB3—melanoma	0.000124	0.000335	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PRKCA—melanoma	0.000124	0.000335	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FLT1—melanoma	0.000123	0.000334	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CG—melanoma	0.000122	0.000331	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SPP1—melanoma	0.000121	0.000329	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MAP2K2—melanoma	0.000121	0.000328	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CXCL8—melanoma	0.000121	0.000327	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SOCS1—melanoma	0.000119	0.000323	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—MAP2K1—melanoma	0.000119	0.000322	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—S100B—melanoma	0.000119	0.000322	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3CD—melanoma	0.000118	0.00032	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FOXO4—melanoma	0.000116	0.000315	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HDAC2—melanoma	0.000116	0.000315	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CXCR4—melanoma	0.000116	0.000315	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—VEGFA—melanoma	0.000116	0.000313	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IL2—melanoma	0.000115	0.000313	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GNAQ—melanoma	0.000115	0.000312	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TERT—melanoma	0.000115	0.000312	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—RAC1—melanoma	0.000115	0.000311	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—NRAS—melanoma	0.000114	0.000309	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ERBB4—melanoma	0.000114	0.000308	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PIK3CB—melanoma	0.000113	0.000307	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CDKN2B—melanoma	0.000113	0.000305	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CG—melanoma	0.000111	0.000301	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HIF1A—melanoma	0.00011	0.000298	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—MAPK3—melanoma	0.000109	0.000296	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CD86—melanoma	0.000109	0.000295	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—CXCL8—melanoma	0.000109	0.000295	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ABCB1—melanoma	0.000109	0.000295	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SYK—melanoma	0.000108	0.000293	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EDN1—melanoma	0.000108	0.000293	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CD—melanoma	0.000107	0.000291	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ITGAV—melanoma	0.000106	0.000288	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AKT3—melanoma	0.000106	0.000288	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NGFR—melanoma	0.000106	0.000288	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FGF1—melanoma	0.000106	0.000286	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CSF2—melanoma	0.000106	0.000286	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—KDR—melanoma	0.000105	0.000285	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—IL2—melanoma	0.000104	0.000282	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—MAPK1—melanoma	0.000104	0.000282	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—E2F1—melanoma	0.000103	0.00028	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3CB—melanoma	0.000103	0.000279	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PDGFRA—melanoma	0.000102	0.000277	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ITGB3—melanoma	0.000101	0.000275	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PRKCA—melanoma	0.000101	0.000275	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—FN1—melanoma	0.000101	0.000274	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PRKCA—melanoma	0.0001	0.000271	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SPP1—melanoma	9.94e-05	0.000269	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ERCC2—melanoma	9.92e-05	0.000269	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NOTCH1—melanoma	9.91e-05	0.000269	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MAP2K2—melanoma	9.9e-05	0.000268	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CXCL8—melanoma	9.89e-05	0.000268	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SOCS1—melanoma	9.83e-05	0.000267	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—KRAS—melanoma	9.82e-05	0.000266	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—MAP2K1—melanoma	9.81e-05	0.000266	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—S100B—melanoma	9.81e-05	0.000266	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CD—melanoma	9.75e-05	0.000264	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CD80—melanoma	9.71e-05	0.000263	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—APC—melanoma	9.69e-05	0.000263	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—KIT—melanoma	9.69e-05	0.000263	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CG—melanoma	9.69e-05	0.000263	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—NRAS—melanoma	9.69e-05	0.000263	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EGF—melanoma	9.58e-05	0.00026	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL2—melanoma	9.45e-05	0.000256	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TERT—melanoma	9.42e-05	0.000255	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—RAC1—melanoma	9.39e-05	0.000255	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ERBB4—melanoma	9.38e-05	0.000254	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CB—melanoma	9.36e-05	0.000254	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CDKN2B—melanoma	9.3e-05	0.000252	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—MAPK3—melanoma	9.28e-05	0.000252	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—BRAF—melanoma	9.11e-05	0.000247	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—PIK3CA—melanoma	9.02e-05	0.000245	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HIF1A—melanoma	9.01e-05	0.000244	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CD86—melanoma	8.99e-05	0.000244	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CXCL8—melanoma	8.99e-05	0.000244	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EDN1—melanoma	8.92e-05	0.000242	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IGF1—melanoma	8.87e-05	0.00024	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—MAPK1—melanoma	8.83e-05	0.000239	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—EGFR—melanoma	8.83e-05	0.000239	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TP53—melanoma	8.73e-05	0.000237	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CSF2—melanoma	8.72e-05	0.000236	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGF1—melanoma	8.72e-05	0.000236	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KDR—melanoma	8.61e-05	0.000234	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—IL2—melanoma	8.59e-05	0.000233	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MAP2K1—melanoma	8.58e-05	0.000232	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—E2F1—melanoma	8.53e-05	0.000231	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CD—melanoma	8.52e-05	0.000231	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CB—melanoma	8.5e-05	0.00023	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PDGFRA—melanoma	8.45e-05	0.000229	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—PIK3CA—melanoma	8.44e-05	0.000229	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ITGB3—melanoma	8.36e-05	0.000227	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PRKCA—melanoma	8.36e-05	0.000227	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—HRAS—melanoma	8.35e-05	0.000226	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—KRAS—melanoma	8.34e-05	0.000226	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FN1—melanoma	8.29e-05	0.000225	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SPP1—melanoma	8.2e-05	0.000222	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAP2K2—melanoma	8.17e-05	0.000222	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CXCL8—melanoma	8.16e-05	0.000221	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—FGF2—melanoma	8.16e-05	0.000221	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NOTCH1—melanoma	8.12e-05	0.00022	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CD80—melanoma	7.95e-05	0.000215	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CG—melanoma	7.94e-05	0.000215	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APC—melanoma	7.94e-05	0.000215	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KIT—melanoma	7.94e-05	0.000215	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—NRAS—melanoma	7.94e-05	0.000215	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EGF—melanoma	7.84e-05	0.000213	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CG—melanoma	7.83e-05	0.000212	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL2—melanoma	7.8e-05	0.000211	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TERT—melanoma	7.77e-05	0.000211	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—RAC1—melanoma	7.75e-05	0.00021	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PIK3CA—melanoma	7.66e-05	0.000208	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MDM2—melanoma	7.63e-05	0.000207	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—MAPK3—melanoma	7.6e-05	0.000206	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PPARG—melanoma	7.56e-05	0.000205	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ERBB2—melanoma	7.52e-05	0.000204	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—BRAF—melanoma	7.46e-05	0.000202	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HIF1A—melanoma	7.43e-05	0.000202	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CB—melanoma	7.43e-05	0.000201	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—AKT1—melanoma	7.37e-05	0.0002	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IGF1—melanoma	7.27e-05	0.000197	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—MAPK1—melanoma	7.23e-05	0.000196	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—EGFR—melanoma	7.23e-05	0.000196	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CXCL8—melanoma	7.14e-05	0.000193	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KDR—melanoma	7.11e-05	0.000193	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—HRAS—melanoma	7.09e-05	0.000192	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MAP2K1—melanoma	7.02e-05	0.00019	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CD—melanoma	6.98e-05	0.000189	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CDKN1B—melanoma	6.97e-05	0.000189	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PIK3CA—melanoma	6.91e-05	0.000187	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—AKT1—melanoma	6.89e-05	0.000187	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CD—melanoma	6.89e-05	0.000187	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FN1—melanoma	6.84e-05	0.000186	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—KRAS—melanoma	6.83e-05	0.000185	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CASP3—melanoma	6.83e-05	0.000185	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL2—melanoma	6.82e-05	0.000185	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ALB—melanoma	6.8e-05	0.000184	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IL6—melanoma	6.79e-05	0.000184	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NOTCH1—melanoma	6.7e-05	0.000182	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FGF2—melanoma	6.68e-05	0.000181	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCND1—melanoma	6.65e-05	0.00018	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CTNNB1—melanoma	6.58e-05	0.000178	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CD80—melanoma	6.56e-05	0.000178	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CG—melanoma	6.55e-05	0.000178	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APC—melanoma	6.55e-05	0.000178	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KIT—melanoma	6.55e-05	0.000178	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—NRAS—melanoma	6.55e-05	0.000178	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EGF—melanoma	6.47e-05	0.000175	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MMP9—melanoma	6.45e-05	0.000175	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CDKN1A—melanoma	6.43e-05	0.000174	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PTEN—melanoma	6.42e-05	0.000174	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NFKB1—melanoma	6.39e-05	0.000173	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3CA—melanoma	6.28e-05	0.00017	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—MAPK3—melanoma	6.27e-05	0.00017	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—AKT1—melanoma	6.26e-05	0.00017	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MDM2—melanoma	6.25e-05	0.000169	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ERBB2—melanoma	6.16e-05	0.000167	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—BRAF—melanoma	6.16e-05	0.000167	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CB—melanoma	6.08e-05	0.000165	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CB—melanoma	6e-05	0.000163	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF1—melanoma	6e-05	0.000163	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—MAPK1—melanoma	5.97e-05	0.000162	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—EGFR—melanoma	5.97e-05	0.000162	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PTGS2—melanoma	5.95e-05	0.000161	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CXCL8—melanoma	5.84e-05	0.000158	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—HRAS—melanoma	5.81e-05	0.000157	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAP2K1—melanoma	5.8e-05	0.000157	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—VEGFA—melanoma	5.8e-05	0.000157	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CD—melanoma	5.76e-05	0.000156	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—STAT3—melanoma	5.74e-05	0.000156	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NRAS—melanoma	5.72e-05	0.000155	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CDKN1B—melanoma	5.71e-05	0.000155	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CA—melanoma	5.7e-05	0.000155	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—AKT1—melanoma	5.64e-05	0.000153	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—KRAS—melanoma	5.64e-05	0.000153	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CASP3—melanoma	5.59e-05	0.000152	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL2—melanoma	5.58e-05	0.000151	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL6—melanoma	5.56e-05	0.000151	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGF2—melanoma	5.51e-05	0.000149	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MAPK3—melanoma	5.48e-05	0.000149	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCND1—melanoma	5.44e-05	0.000148	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CTNNB1—melanoma	5.39e-05	0.000146	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MYC—melanoma	5.33e-05	0.000145	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MMP9—melanoma	5.29e-05	0.000143	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CDKN1A—melanoma	5.27e-05	0.000143	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PTEN—melanoma	5.25e-05	0.000142	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NFKB1—melanoma	5.23e-05	0.000142	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MAPK1—melanoma	5.22e-05	0.000141	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EGFR—melanoma	5.22e-05	0.000141	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PTEN—melanoma	5.19e-05	0.000141	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CA—melanoma	5.18e-05	0.00014	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MDM2—melanoma	5.16e-05	0.00014	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—AKT1—melanoma	5.13e-05	0.000139	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ERBB2—melanoma	5.09e-05	0.000138	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CB—melanoma	5.02e-05	0.000136	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—KRAS—melanoma	4.93e-05	0.000134	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CXCL8—melanoma	4.82e-05	0.000131	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—HRAS—melanoma	4.79e-05	0.00013	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—VEGFA—melanoma	4.75e-05	0.000129	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CDKN1B—melanoma	4.71e-05	0.000128	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—STAT3—melanoma	4.7e-05	0.000127	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NRAS—melanoma	4.69e-05	0.000127	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—AKT1—melanoma	4.66e-05	0.000126	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CASP3—melanoma	4.62e-05	0.000125	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL2—melanoma	4.61e-05	0.000125	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL6—melanoma	4.59e-05	0.000124	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CA—melanoma	4.53e-05	0.000123	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCND1—melanoma	4.49e-05	0.000122	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MAPK3—melanoma	4.49e-05	0.000122	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CTNNB1—melanoma	4.45e-05	0.000121	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TP53—melanoma	4.38e-05	0.000119	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MYC—melanoma	4.37e-05	0.000118	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MMP9—melanoma	4.36e-05	0.000118	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CDKN1A—melanoma	4.35e-05	0.000118	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PTEN—melanoma	4.34e-05	0.000118	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NFKB1—melanoma	4.32e-05	0.000117	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MAPK1—melanoma	4.27e-05	0.000116	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EGFR—melanoma	4.27e-05	0.000116	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AKT1—melanoma	4.23e-05	0.000115	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HRAS—melanoma	4.19e-05	0.000114	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KRAS—melanoma	4.03e-05	0.000109	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL6—melanoma	4.01e-05	0.000109	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—VEGFA—melanoma	3.92e-05	0.000106	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—STAT3—melanoma	3.88e-05	0.000105	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NRAS—melanoma	3.87e-05	0.000105	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CA—melanoma	3.71e-05	0.0001	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAPK3—melanoma	3.71e-05	0.0001	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AKT1—melanoma	3.7e-05	0.0001	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CA—melanoma	3.66e-05	9.92e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MYC—melanoma	3.6e-05	9.77e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TP53—melanoma	3.59e-05	9.72e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAPK1—melanoma	3.53e-05	9.56e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EGFR—melanoma	3.52e-05	9.55e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HRAS—melanoma	3.43e-05	9.3e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KRAS—melanoma	3.33e-05	9.03e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL6—melanoma	3.28e-05	8.9e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CA—melanoma	3.06e-05	8.29e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AKT1—melanoma	3.03e-05	8.21e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—AKT1—melanoma	2.99e-05	8.1e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TP53—melanoma	2.96e-05	8.02e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HRAS—melanoma	2.83e-05	7.67e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL6—melanoma	2.71e-05	7.34e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AKT1—melanoma	2.5e-05	6.77e-05	CbGpPWpGaD
